“Northeast Fishing & Hunting Show” Coming March

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
227
“Northeast Fishing & Hunting Show” Coming March 31-April 2, 2017 to Connecticut Convention Center in Hartford

HARTFORD, Conn., Jan. 12, 2017 (GLOBE NEWSWIRE) -- Big news for New England fishing and hunting enthusiasts: the “Northeast Fishing & Hunting Show, engineered by GMC ” will be six weeks later than in past years – just in time for spring’s fishing and hunting season! The 20 th event will be Friday, March 31 through Sunday, April 2, 2017 at the Connecticut Convention Center, 100 Columbus Blvd. in Hartford, Conn.

“Connecticut’s only fishing & hunting show will be fun and useful for people gearing up for this spring’s outdoor season,” explains show organizer Kristie Gonsalves, President of North East Expos. “This is a great outing for the entire family with hundreds of booths of the newest fishing, hunting and outdoor equipment for sale by some of the nation’s top manufacturers, including a variety of fishing boats. Attendees can attend 50 hours of seminars with national and regional experts, speak with charter boat captains, watch expert fly fishing casting and fly tying shows, and enjoy many activities."

Experts include: Alberto Knie (a/k/a “Crazy Alberto”) – world-class extreme trophy game fish hunter, writer and product designer who specializes in Trophy Fishing and Conservation; whitetail hunters Dean and Shelli Vanier; Gerry Rightmyer & Steve Schicker, hosts of TV’s “Forever Wild Outdoors Adrenaline Adventure” ; international bow hunter Del DelMastro; Angler and Bassmaster Mike DelVisco; Ralph Wilkins of National Geographic Channel’s “ Wicked Tuna” ; diving fisherman Mike Laptew; lure designer Al Gag; and Fishing Captains Brian Bacon, Greg Dubrule, TJ Karbowski, John Planeta, Mike Roy, Mel True, and Dave Brandt.

New this year is a 4,000-gallon Hog Traugh Fish Tank for fishing and casting demonstrations. Returning favorites include: hunting and pointing dog demonstrations from Dusty W German Shorthaired Pointers of Palmerton, Penn.; live eagles, owls and hawks of Talons! Birds of Prey ; a Catch & Release Trout Pond for prizes; an interactive virtual fishing fighting chair; NRA Laser Shooting Range; Sportsmen’s Outpost’s archery range; and Connecticut Bass Federation’s Kids’ Bass Casting Competition.

Lang’s Auction, the world’s largest auction firm, will provide free appraisals of antique and collectible fishing lure and tackle.

The Connecticut Department of Energy & Environmental Protection (DEEP)’s booths will feature mounted fish and animals and a tank of live fish. DEEP experts will provide consumer education on many topics, and present the latest fishing and hunting rules and regulations. A U.S. Department of Veterans Affairs’ Mobile VetCenter Bus will be staffed by outreach representatives.

Hours : Friday, March 31 from 12 noon to 8 p.m.; Saturday, April 1 from 10 a.m. to 7 p.m.; and Sunday, April 2 from 10 a.m. to 5 p.m.

Admission - cash only : $12 adults; $4 Children 5 to 12; Free under age 5. April 1: first 200 veterans in line get in free with ID.

Sponsors include: GMC, Coalition of Connecticut Sportsmen, The Fisherman Magazine, LeafFilter of Connecticut.

www.fishinghuntingshow.com or 860-844-8461 or Facebook.

MEDIA CONTACT: Laura Soll, 860-688-4499 or Cell 860-833-4466, Laura@sollpr.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading